1. Home
  2. XNCR vs CMRE Comparison

XNCR vs CMRE Comparison

Compare XNCR & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$33.57

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

N/A

Current Price

$12.32

Market Cap

1.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
XNCR
CMRE
Founded
1997
1974
Country
United States
Monaco
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
XNCR
CMRE
Price
$33.57
$12.32
Analyst Decision
Buy
Strong Buy
Analyst Count
14
2
Target Price
★ $43.83
$20.00
AVG Volume (30 Days)
★ 1.5M
408.7K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
★ 3.96%
EPS Growth
★ 65.36
N/A
EPS
N/A
★ N/A
Revenue
★ $125,576,000.00
N/A
Revenue This Year
$58.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.55
Revenue Growth
★ 13.65
N/A
52 Week Low
$10.38
$12.15
52 Week High
$40.60
$18.06

Technical Indicators

Market Signals
Indicator
XNCR
CMRE
Relative Strength Index (RSI) 54.03 29.30
Support Level $22.80 N/A
Resistance Level $33.60 $15.76
Average True Range (ATR) 2.08 0.40
MACD -0.54 -0.03
Stochastic Oscillator 35.21 9.66

Price Performance

Historical Comparison
XNCR
CMRE

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: